Global Oncology News Neoadjuvant HER2+Acute Myeloid Leukemia: Evolving Perspectives on Testing, Targeted Therapies, and Transplantation AML: Evolving Perspectives on Testing, Therapies, & Transplantation Join us to learn about the impact of MRD in cancer

Global Oncology News Neoadjuvant HER2+Acute Myeloid Leukemia: Evolving Perspectives on Testing, Targeted Therapies, and Transplantation AML: Evolving Perspectives on Testing, Therapies, & Transplantation Join us to learn about the impact of MRD in cancer

View More Biosimilars Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Head & Neck Cancers Hematologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma

Biosimilars Breast Cancer Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Head & Neck Cancers Hematologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma

All Oncology News

Pipeline Report

Rare Cancer Series

OncClub All Oncology News Pipeline Report Rare Cancer Series

Medical World News

Thoracic Night Live

Insights Medical World News News Network OncLive TV Peer Exchange Podcasts Rapid Readouts The Talk Thoracic Night Live

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Giants of Cancer Care

Scientific Interchanges

State of the Science Summit / IPC

Giants of Cancer Care PER Events Scientific Interchanges State of the Science Summit / IPC Webinars

Oncology Fellows

Supplements And Featured Publications

All Publications

Oncology Live Oncology Fellows Supplements And Featured Publications All Publications

Interactive Tools

Learning Modules

Community Interactive Tools Learning Modules Partners Sponsored

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

© 2021 MJH Life Sciences and OncLive. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Global Oncology News
Neoadjuvant HER2+
Acute Myeloid Leukemia: Evolving Perspectives on Testing, Targeted Therapies, and Transplantation
AML: Evolving Perspectives on Testing, Therapies, & Transplantation
Join us to learn about the impact of MRD in cancer

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

OncLive SOSS

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2021 MJH Life Sciences^™ and OncLive. All rights reserved.

Treating Advanced RAI-Refractory DTC: A Two-Way Street: Medical Oncology and Endocrinology

Differentiated Thyroid Cancer: Increasing Incidence

December 14th 2020

DTC: Histological Subtypes and Tumor Differentiation

December 14th 2020

Role of Radioiodine Treatment in DTC

December 21st 2020

Thyrotropin Suppression as DTC Treatment Option

December 21st 2020

Clinical Scenarios to Consider for RAI-Refractory DTC

January 4th 2021

Discussing Iodine-Refractory DTC With Patients

January 4th 2021

Management of DTC in Clinical Practice

January 11th 2021

Roles and Communication in Treatment in DTC

January 11th 2021

Understanding Sequencing and What to Look for in DTC

January 18th 2021

Approaching Treatment of Low-Volume DTC

January 18th 2021